T. Rowe Price Associates’s Sonnet BioTherapeutics SONN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18	Closed	-$19K	–	3007
2021 Q4	$19K	Hold	18	–	–	﹤0.01%	2960
2021 Q3	$27K	Hold	18	–	–	﹤0.01%	2919
2021 Q2	$71K	Hold	18	–	–	﹤0.01%	2870
2021 Q1	$101K	Buy	+18	New	+$101K	﹤0.01%	2775